The impact of IBD medications on risk of pneumonia and pneumonia‐related hospitalisation: a nationwide cohort study of 56 410 IBD patients-Reference-Cited by-同舟云学术

The impact of IBD medications on risk of pneumonia and pneumonia‐related hospitalisation: a nationwide cohort study of 56 410 IBD patients

Published:2021-10-19 Issue:1 Volume:55 Page:64-72
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Khan Nabeel¹²^ORCID,Patel Dhruvan²,Trivedi Chinmay¹,Pernes Tyler¹,Kavani Himanshu¹³,Xie Dawei⁴,Yang Yu‐Xiao¹²⁵^ORCID

Affiliation:

1. Corporal Michael J. Crescenz VA Medical Center Philadelphia PA USA

2. Division of Gastroenterology University of Pennsylvania Perelman School of Medicine Philadelphia PA USA

3. St. Mary Medical Center Langhorne PA USA

4. Department of Epidemiology and Biostatistics University of Pennsylvania Perelman School of Medicine Philadelphia PA USA

5. Center of Clinical Epidemiology and Biostatistics University of Pennsylvania Perelman School of Medicine Philadelphia PA USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16610

Reference26 articles.

1. Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years — United States, 2015

2. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

3. Elderly patients and inflammatory bowel disease

4. Risk of infection and types of infection among elderly patients with inflammatory bowel disease: a retrospective database analysis;Khan N;Inflamm Bowel Dis,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bidirectional association between pneumonia and intestinal infection: an analysis of the MIMIC-IV database;Internal and Emergency Medicine;2024-05-08

2. Microbiota and Immunity during Respiratory Infections: Lung and Gut Affair;International Journal of Molecular Sciences;2024-04-05

3. Patients With Inflammatory Bowel Disease Are at Increased Risk of Hospitalization Due to Respiratory Syncytial Virus;American Journal of Gastroenterology;2024-03-21

4. A new perspective on gut-lung axis affected through resident microbiome and their implications on immune response in respiratory diseases;Archives of Microbiology;2024-02-18

5. The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—IBD in Seniors;Journal of the Canadian Association of Gastroenterology;2023-09-01